<DOC>
	<DOCNO>NCT02958072</DOCNO>
	<brief_summary>An International Multicenter study evaluation , effect fully autologous growth factor-containing patch LeucoPatch , heal recalcitrant malleoli ulcer patient diabetes . To compare impact LeucoPatch part usual care multidisciplinary Diabetes Foot clinic setting , versus usual care clinic malleoli ulcer heal .</brief_summary>
	<brief_title>LeucoPatch Diabetic Malleoli Ulcer Study</brief_title>
	<detailed_description>Diabetic Foot Ulcers common severe complication , affect Patients Life Quality . Healing time often long Diabetic foot ulcer dominate traumatic reason leg amputation . Treatment diabetic foot ulcer require debridement , offload , regularly foot care , specially tailor shoe , antimicrobial treatment , sometimes even surgical intervention . Despite intervention diabetic foot ulcer may heal . Research show method Growth factor may way enhance chance heal . Growth Factors show positive effect study , product characterize autologous yet obtain positive result control study . LeucoPatch produce solely patient´s blood without addition , autologous . LeucoPatch appear elastic membrane fit individual ulcer . LeucoPatch show contain many growth factor exist product , high concentration fibrin , platelet leukocytes . A non-controlled study make ulcer less 10cm 2 52 % compete epithelization 20 week . An International randomize multicenter trial ongoing evaluate efficacy safety LeucoPatch heal hard heal diabetic foot ulcer malleoli . This Study design test heal effect LeucoPatch malleoli ulcer , Patient randomize heal confirm blind observer .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<criteria>Diabetes mellitus Foot ulcer malleoli area 0,25 cm² 5,0 cm² Foot ulcer duration 6 week Anklebrachial index 0,40 presence palpable pulse arteria dorsalis pes and/or arteria tibialis posterior informed consent Hemoglobin concentration 6.5 mmol/l screen HBA1c 108 mmol/l Noncompliant bloodletting Clinically infect ulcer Patient plan revascularization procedure affect leg within last 8 week The ulcer treat growth factor last 8 week History deep venous insufficiency , chronic venous leg ulcer stasis dermatitis Breastfeeding woman fertile woman agree use effective method contraception Participation another clinical ulcerhealing study within last 4 week Patient previously randomize study Judgement investigator patient able participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Malleoli ulcer</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Healing</keyword>
	<keyword>Dressing</keyword>
	<keyword>LeucoPatch</keyword>
</DOC>